We are live on
!
Find out more
HEC
Hudson Executive Capital Portfolio holdings
AUM
$151M
1-Year Est. Return
60.14%
This Fund
S&P 500
This Quarter
Est. Return
-6.59%
1 Year Est. Return
+60.14%
3 Year Est. Return
+143.92%
5 Year Est. Return
+104.85%
10 Year Est. Return
+677.02%
AUM
$1.42B
AUM Growth
-$84.2M
(-5.6%)
Cap. Flow
+$38.9M
Cap. Flow
% of AUM
2.74%
Top 10 Holdings %
Top 10 Hldgs %
99.83%
Holding
13
New
4
Increased
2
Reduced
–
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Blend Labs
BLND
|
+$17M |
| 2 |
AKYA
Akoya BioSciences
AKYA
|
+$13M |
| 3 |
flyExclusive
FLYX
|
+$2.35M |
| 4 |
Talkspace
TALK
|
+$1.05M |
| 5 |
flyExclusive Inc Warrants
FLYX.WS
|
+$63.3K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EGGF.U
EG Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant
EGGF.U
|
+$2.49M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 64.87% |
| 2 | Healthcare | 16.86% |
| 3 | Technology | 10.04% |
| 4 | Industrials | 0.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Deutsche Bank
DB
$65.3B
| $862M | 60.6% |
67,389,676
| – | – |
|
|
CTLP
2
DELISTED
Cantaloupe
CTLP
| $129M | 9.1% |
11,995,765
| – | – |
|
|
TVTY
3
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $111M | 7.78% |
4,795,310
| – | – |
|
|
VRAY
4
DELISTED
ViewRay, Inc.
VRAY
| $107M | 7.49% |
14,774,684
| – | – |
|
5
Natera
NTRA
$37.9B
| $65.6M | 4.62% |
588,886
| – | – |
|
6
eHealth
EHTH
$42.9M
| $60.8M | 4.28% |
1,501,002
| – | – |
|
|
7
Talkspace
TALK
$873M
| $37.7M | 2.65% |
10,340,600
+190,600
| +2% | +$1.05M |
|
|
AKYA
8
DELISTED
Akoya BioSciences
AKYA
| $25.8M | 1.82% |
1,849,843
+779,859
| +73% | +$13M |
|
|
9
Blend Labs
BLND
$409M
| $13.5M | 0.95% |
+1,000,000
| New | +$17M |
|
|
10
flyExclusive
FLYX
$58.5M
| $2.36M | 0.17% |
+242,849
| New | +$2.35M |
|
|
11
flyExclusive Inc Warrants
FLYX.WS
| $48K | ﹤0.01% |
+80,949
| New | +$63.3K |
|
|
EGGF.U
12
DELISTED
EG Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant
EGGF.U
| – | – |
-248,874
| Closed | -$2.49M |
|
Similar funds
SHF
CCM
DIG
BDS
MWA
WBCM
CAM
BA
Hudson Executive Capital's Q3 2021 Portfolio in Review
As of Q3 2021, Hudson Executive Capital held 13 positions worth $1.42B, down 5.6% from $1.51B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Hudson Executive Capital's Q3 2021 filing shows 4 new, 2 increased and 1 closed positions. Its largest new stake was Blend Labs: 1,000,000 shares worth $13.5M. The largest sale was EG Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant, an estimated $2.49M.
By sector, the portfolio is most concentrated in Financials at 65% of assets, up from 64% a quarter earlier, followed by Healthcare and Technology.
- Hudson Executive Capital's largest Q3 2021 buy was Blend Labs: 1,000,000 shares worth $13.5M.
- Hudson Executive Capital added most to Akoya BioSciences in Q3 2021, an estimated $13M increase.
- Hudson Executive Capital fully exited EG Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant in Q3 2021, selling an estimated $2.49M.
- Hudson Executive Capital's ten largest holdings make up 100% of its $1.42B portfolio in Q3 2021.
- Hudson Executive Capital opened 4 new positions and closed 1 in Q3 2021.
- Hudson Executive Capital's portfolio value fell 5.6% quarter-over-quarter to $1.42B.
Based on Hudson Executive Capital's 13F filing for Q3 2021, filed 15 Nov 2021.